Public Employees Retirement System of Ohio Reduces Holdings in HCA Healthcare, Inc. $HCA

Public Employees Retirement System of Ohio decreased its position in HCA Healthcare, Inc. (NYSE:HCA) by 8.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 75,774 shares of the company’s stock after selling 6,995 shares during the period. Public Employees Retirement System of Ohio’s holdings in HCA Healthcare were worth $29,029,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the stock. IMS Capital Management purchased a new position in shares of HCA Healthcare during the 2nd quarter worth approximately $211,000. Fifth Third Bancorp boosted its position in shares of HCA Healthcare by 2.0% during the 2nd quarter. Fifth Third Bancorp now owns 9,350 shares of the company’s stock worth $3,582,000 after purchasing an additional 186 shares during the period. Argent Capital Management LLC boosted its position in shares of HCA Healthcare by 1.2% during the 2nd quarter. Argent Capital Management LLC now owns 230,421 shares of the company’s stock worth $88,274,000 after purchasing an additional 2,841 shares during the period. Oliver Luxxe Assets LLC boosted its position in shares of HCA Healthcare by 4.7% during the 2nd quarter. Oliver Luxxe Assets LLC now owns 13,137 shares of the company’s stock worth $5,033,000 after purchasing an additional 587 shares during the period. Finally, CJM Wealth Advisers Ltd. purchased a new position in HCA Healthcare in the 2nd quarter valued at approximately $205,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $416.68 on Thursday. The company’s fifty day moving average price is $387.59 and its 200 day moving average price is $367.58. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $420.98. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86. The firm has a market capitalization of $97.50 billion, a P/E ratio of 17.51, a P/E/G ratio of 1.29 and a beta of 1.41.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. During the same period last year, the business earned $5.50 EPS. HCA Healthcare’s revenue for the quarter was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 12.11%.

Wall Street Analysts Forecast Growth

HCA has been the subject of several recent research reports. Cantor Fitzgerald reissued an “overweight” rating and issued a $444.00 price target on shares of HCA Healthcare in a research report on Tuesday, August 26th. Royal Bank Of Canada decreased their price target on shares of HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating for the company in a research report on Monday, July 28th. Robert W. Baird raised their price target on shares of HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a research report on Thursday, August 14th. Wall Street Zen raised shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, July 5th. Finally, Stephens upgraded shares of HCA Healthcare to a “strong-buy” rating in a report on Monday, June 2nd. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $407.75.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.